Argenx Se (ARGX) EBT Margin (QoQ) (2017 - 2026)

Argenx Se (ARGX) EBT Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 102.00
Mar 31, 2026 238.00
Dec 31, 2025 -289.00
Sep 30, 2025 401.00
Jun 30, 2025 463.00
Mar 31, 2025 1,424.00
Dec 31, 2024 -398.00
Sep 30, 2024 1,850.00
Jun 30, 2024 1,553.00
Mar 31, 2024 -233.00
Dec 31, 2023 896.00
Sep 30, 2023 -5,644.00
Jun 30, 2023 -380.00
Mar 31, 2023 1,116.00
Dec 31, 2022 -15,974.00
Sep 30, 2022 108,837.00
Jun 30, 2022 -199,199.00
Mar 31, 2022 14,609.00
Dec 31, 2021 94,108.00
Sep 30, 2021 -3,343.00